Autoimmune disease prevalence in a multiple sclerosis cohort in Argentina
- PMID: 25170425
- PMCID: PMC4142150
- DOI: 10.1155/2014/828162
Autoimmune disease prevalence in a multiple sclerosis cohort in Argentina
Abstract
Background. Comorbid autoimmune diseases in MS patients have been studied extensively with controversial results. Moreover, no such data exists for Latin-American MS patients. Methods. We conducted a case-control study aimed to establish the prevalence of autoimmune disorders in a cohort of Argentinean MS patients. Results. There were no significant differences in autoimmune disease prevalence in MS patients with respect to controls. The presence of one or more autoimmune disorders did not increase risk of MS (OR 0.85, 95% CI 0.6-1.3). Discussion. Our results indicate absence of increased comorbid autoimmune disease prevalence in MS patients, as well as of increased risk of MS in patients suffering from other autoimmune disorders.
References
-
- Compston A, Coles A. Multiple sclerosis. The Lancet. 2008;372(9648):1502–1517. - PubMed
-
- Dobson R, Giovannoni G. Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis. Journal of Neurology. 2013:1–14. - PubMed
-
- Barcellos LF, Kamdar BB, Ramsay PP, et al. Clustering of autoimmune diseases in families with a high-risk for multiple sclerosis: a descriptive study. The Lancet Neurology. 2006;5(11):924–931. - PubMed
-
- Roshanisefat H, Bahmanyar S, Hillert J, Olsson T, Montgomery S. Shared genetic factors may not explain the raised risk of comorbid inflammatory diseases in multiple sclerosis. Multiple Sclerosis. 2012;18(10):1430–1436. - PubMed
-
- Disanto G, Ramagopalan SV. Multiple sclerosis and co-morbid autoimmune disease: the final nail in the coffin? Multiple Sclerosis. 2012;18(10):1370–1371. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources